Codon 200 mutation of the prion gene: genotype-phenotype correlations
- PMID: 22584955
- DOI: 10.1007/s00415-012-6539-x
Codon 200 mutation of the prion gene: genotype-phenotype correlations
Abstract
Genetic mutations as a cause of prion diseases are rare. We describe a large family with multiple affected members with the codon E200K prion mutation. To improve understanding of the genotype-phenotype correlations of prion gene mutations, clinical, genetic and neuropathological data were obtained from family members over 15 years. Six patients with the codon E200K mutation and 2 patients without the codon 200 mutation from this family were followed. The 6 patients with the codon 200 mutation had a mean age onset of 58.83 years (SD 7.2; lower 95 % CI 51.0; upper 95 % CI 66.4). The most common symptoms at onset were memory loss, walking difficulties and hallucinations. The most frequent neurological phenomena were a rapidly progressive dementia, eye movement abnormalities and ataxia. The mean duration of onset of symptoms to death was 3.9 months (SD 1.1; lower 95 % CI 2.8; upper 95 % CI 5.1). Two male patients developed neurodegenerative disorders unrelated to the prion codon 200 mutation: progressive supranuclear palsy and olivopontocerebellar degeneration. Their mean survival was 96 months (SD 33.9; p < 0.0001). Individuals from families with the prion codon 200 mutation may have a rapidly progressive dementia. Members of families with inherited prion mutations may be at risk of other neurodegenerative disorders unrelated to the prion mutation.
Similar articles
-
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.Brain. 1999 Oct;122 ( Pt 10):1823-37. doi: 10.1093/brain/122.10.1823. Brain. 1999. PMID: 10506086
-
Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129.Neurology. 2007 Aug 21;69(8):730-8. doi: 10.1212/01.wnl.0000267642.41594.9d. Neurology. 2007. PMID: 17709704
-
Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity.Brain. 2006 Sep;129(Pt 9):2297-317. doi: 10.1093/brain/awl226. Brain. 2006. PMID: 16923955
-
The genetics of prion diseases.Genet Med. 2010 Apr;12(4):187-95. doi: 10.1097/GIM.0b013e3181cd7374. Genet Med. 2010. PMID: 20216075 Review.
-
Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):36-69. doi: 10.1002/ajmg.b.32505. Am J Med Genet B Neuropsychiatr Genet. 2017. PMID: 27943639 Free PMC article. Review.
Cited by
-
Prion diseases: immunotargets and therapy.Immunotargets Ther. 2016 Jun 16;5:57-68. doi: 10.2147/ITT.S64795. eCollection 2016. Immunotargets Ther. 2016. PMID: 27529062 Free PMC article. Review.
-
Lacritin and other autophagy associated proteins in ocular surface health.Exp Eye Res. 2016 Mar;144:4-13. doi: 10.1016/j.exer.2015.08.015. Epub 2015 Aug 25. Exp Eye Res. 2016. PMID: 26318608 Free PMC article. Review.
-
Movement Disorders in Prionopathies: A Systematic Review.Tremor Other Hyperkinet Mov (N Y). 2019 Dec 12;9. doi: 10.7916/tohm.v0.712. eCollection 2019. Tremor Other Hyperkinet Mov (N Y). 2019. PMID: 31871824 Free PMC article.
-
Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation.BMC Med Genomics. 2014 Aug 22;7:52. doi: 10.1186/1755-8794-7-52. BMC Med Genomics. 2014. PMID: 25149502 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
